OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Repurposing antidepressants for anticancer drug discovery
Yihui Song, Xiaoke Yang, Bin Yu
Drug Discovery Today (2021) Vol. 27, Iss. 7, pp. 1924-1935
Closed Access | Times Cited: 31
Yihui Song, Xiaoke Yang, Bin Yu
Drug Discovery Today (2021) Vol. 27, Iss. 7, pp. 1924-1935
Closed Access | Times Cited: 31
Showing 1-25 of 31 citing articles:
Targeting epigenetic regulators to overcome drug resistance in cancers
Nan Wang, Ting Ma, Bin Yu
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 147
Nan Wang, Ting Ma, Bin Yu
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 147
LSD1 inhibitors for cancer treatment: Focus on multi-target agents and compounds in clinical trials
Beatrice Noce, Elisabetta Di Bello, Rossella Fioravanti, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 72
Beatrice Noce, Elisabetta Di Bello, Rossella Fioravanti, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 72
Drug repurposing: An effective strategy to accelerate contemporary drug discovery
Peng Zhan, Bin Yu, Liang Ouyang
Drug Discovery Today (2022) Vol. 27, Iss. 7, pp. 1785-1788
Open Access | Times Cited: 39
Peng Zhan, Bin Yu, Liang Ouyang
Drug Discovery Today (2022) Vol. 27, Iss. 7, pp. 1785-1788
Open Access | Times Cited: 39
Antidepressants for the treatment of depression in people with cancer
Giovanni Vita, Beatrice Compri, Faith Matcham, et al.
Cochrane library (2023) Vol. 2023, Iss. 3
Open Access | Times Cited: 37
Giovanni Vita, Beatrice Compri, Faith Matcham, et al.
Cochrane library (2023) Vol. 2023, Iss. 3
Open Access | Times Cited: 37
A second life for MAO inhibitors? From CNS diseases to anticancer therapy
Sabina Sblano, Angelina Boccarelli, Francesco Mesiti, et al.
European Journal of Medicinal Chemistry (2024) Vol. 267, pp. 116180-116180
Open Access | Times Cited: 8
Sabina Sblano, Angelina Boccarelli, Francesco Mesiti, et al.
European Journal of Medicinal Chemistry (2024) Vol. 267, pp. 116180-116180
Open Access | Times Cited: 8
Annual review of lysine-specific demethylase 1 (LSD1/KDM1A) inhibitors in 2021
Yihui Song, Huiqing Zhang, Xiaoke Yang, et al.
European Journal of Medicinal Chemistry (2021) Vol. 228, pp. 114042-114042
Closed Access | Times Cited: 47
Yihui Song, Huiqing Zhang, Xiaoke Yang, et al.
European Journal of Medicinal Chemistry (2021) Vol. 228, pp. 114042-114042
Closed Access | Times Cited: 47
Strategies that regulate LSD1 for novel therapeutics
Meng Li, Mengge Dai, Bingchuan Cheng, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 4, pp. 1494-1507
Open Access | Times Cited: 5
Meng Li, Mengge Dai, Bingchuan Cheng, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 4, pp. 1494-1507
Open Access | Times Cited: 5
Recent advances of LSD1/KDM1A inhibitors for disease therapy
Chaofeng Zhang, Zhiyuan Wang, Yuting Shi, et al.
Bioorganic Chemistry (2023) Vol. 134, pp. 106443-106443
Closed Access | Times Cited: 12
Chaofeng Zhang, Zhiyuan Wang, Yuting Shi, et al.
Bioorganic Chemistry (2023) Vol. 134, pp. 106443-106443
Closed Access | Times Cited: 12
JBI-802: the first orally available LSD1/HDAC6 dual inhibitor to enter clinical trials
Jingya Zhang, Xiangli Ren, Yihui Song, et al.
Expert Opinion on Therapeutic Patents (2025)
Closed Access
Jingya Zhang, Xiangli Ren, Yihui Song, et al.
Expert Opinion on Therapeutic Patents (2025)
Closed Access
Targeting TGF-β: a promising strategy for cancer therapy
Himani Rathi, Charanjit Kaur, Rajesh Kumar, et al.
Medical Oncology (2025) Vol. 42, Iss. 5
Closed Access
Himani Rathi, Charanjit Kaur, Rajesh Kumar, et al.
Medical Oncology (2025) Vol. 42, Iss. 5
Closed Access
Unravelling the target landscape of tranylcypromines for new drug discovery
Yihui Song, Junbiao Chang, Bin Yu
Acta Pharmaceutica Sinica B (2025)
Open Access
Yihui Song, Junbiao Chang, Bin Yu
Acta Pharmaceutica Sinica B (2025)
Open Access
Discovery of natural product-like spirooxindole derivatives as highly potent and selective LSD1/KDM1A inhibitors for AML treatment
Chao Yang, Yuan Fang, Xiang Luo, et al.
Bioorganic Chemistry (2022) Vol. 120, pp. 105596-105596
Closed Access | Times Cited: 18
Chao Yang, Yuan Fang, Xiang Luo, et al.
Bioorganic Chemistry (2022) Vol. 120, pp. 105596-105596
Closed Access | Times Cited: 18
Structural and Functional Landscape of FAD-Dependent Histone Lysine Demethylases for New Drug Discovery
Yihui Song, Shu Wang, Bin Yu
Journal of Medicinal Chemistry (2022) Vol. 66, Iss. 1, pp. 71-94
Closed Access | Times Cited: 17
Yihui Song, Shu Wang, Bin Yu
Journal of Medicinal Chemistry (2022) Vol. 66, Iss. 1, pp. 71-94
Closed Access | Times Cited: 17
Antidepressants as Autophagy Modulators for Cancer Therapy
Leping He, Yuanfeng Fu, Yuxi Tian, et al.
Molecules (2023) Vol. 28, Iss. 22, pp. 7594-7594
Open Access | Times Cited: 10
Leping He, Yuanfeng Fu, Yuxi Tian, et al.
Molecules (2023) Vol. 28, Iss. 22, pp. 7594-7594
Open Access | Times Cited: 10
Beyond Psychotropic: Repurposing of Fluoxetine Toward Cancer Management and Its Molecular Mechanisms
Sultan Kadasah, Abdulaziz M. Alqahtani, Mohamed O. Radwan
(2024)
Open Access | Times Cited: 2
Sultan Kadasah, Abdulaziz M. Alqahtani, Mohamed O. Radwan
(2024)
Open Access | Times Cited: 2
Ameliorative effect of fluvoxamine against colon carcinogenesis via COX-2 blockade with oxidative and metabolic stress reduction at the cellular, molecular and metabolic levels
Pranesh Kumar, Mohit Kumar, Anurag Gautam, et al.
BBA Advances (2022) Vol. 2, pp. 100046-100046
Open Access | Times Cited: 9
Pranesh Kumar, Mohit Kumar, Anurag Gautam, et al.
BBA Advances (2022) Vol. 2, pp. 100046-100046
Open Access | Times Cited: 9
The Antidepressant Drug Amitriptyline Affects Human SH-SY5Y Neuroblastoma Cell Proliferation and Modulates Autophagy
Annagrazia Adornetto, Maria Luisa Laganà, Andrea Satriano, et al.
(2024)
Open Access | Times Cited: 1
Annagrazia Adornetto, Maria Luisa Laganà, Andrea Satriano, et al.
(2024)
Open Access | Times Cited: 1
Antidepressant Sertraline Synergistically Enhances Paclitaxel Efficacy by Inducing Autophagy in Colorectal Cancer Cells
Leping He, Yuxi Tian, Qingqing Liu, et al.
Molecules (2024) Vol. 29, Iss. 16, pp. 3733-3733
Open Access | Times Cited: 1
Leping He, Yuxi Tian, Qingqing Liu, et al.
Molecules (2024) Vol. 29, Iss. 16, pp. 3733-3733
Open Access | Times Cited: 1
Targeting MAO-B with Small-Molecule Inhibitors: A Decade of Advances in Anticancer Research (2012–2024)
Iyman Alsaad, Dalil Rahman, Ola Al-Tamimi, et al.
Molecules (2024) Vol. 30, Iss. 1, pp. 126-126
Open Access | Times Cited: 1
Iyman Alsaad, Dalil Rahman, Ola Al-Tamimi, et al.
Molecules (2024) Vol. 30, Iss. 1, pp. 126-126
Open Access | Times Cited: 1
Combining EGFR inhibitors with SHP2 or LSD1 inhibitors to overcome multidrug resistance in cancer
Huiqing Zhang, Xinyu Yang, Yihui Song, et al.
Future Medicinal Chemistry (2022) Vol. 14, Iss. 8, pp. 527-529
Closed Access | Times Cited: 7
Huiqing Zhang, Xinyu Yang, Yihui Song, et al.
Future Medicinal Chemistry (2022) Vol. 14, Iss. 8, pp. 527-529
Closed Access | Times Cited: 7
The toxic compounds from citrus parasite (Scurrula ferruginea (Jack) Danser.)
Wiwik Susanah Rita, Ni Kadek Novita Yulandari, Ni Luh Rustini
AIP conference proceedings (2024) Vol. 3079, pp. 020003-020003
Open Access
Wiwik Susanah Rita, Ni Kadek Novita Yulandari, Ni Luh Rustini
AIP conference proceedings (2024) Vol. 3079, pp. 020003-020003
Open Access
Beyond Psychotropic: Potential Repurposing of Fluoxetine toward Cancer Therapy
Sultan Kadasah, Abdulaziz M. Alqahtani, Abdullah Alkhammash, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 12, pp. 6314-6314
Open Access
Sultan Kadasah, Abdulaziz M. Alqahtani, Abdullah Alkhammash, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 12, pp. 6314-6314
Open Access
Physicochemical properties and thermodynamic parameters of tricyclic amphiphilic drugs
Harikesh Narayanan, Ajmal Koya Pulikkal
Journal of Molecular Liquids (2024) Vol. 410, pp. 125550-125550
Closed Access
Harikesh Narayanan, Ajmal Koya Pulikkal
Journal of Molecular Liquids (2024) Vol. 410, pp. 125550-125550
Closed Access
The Antidepressant Drug Amitriptyline Affects Human SH-SY5Y Neuroblastoma Cell Proliferation and Modulates Autophagy
Annagrazia Adornetto, Maria Luisa Laganà, Andrea Satriano, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 19, pp. 10415-10415
Open Access
Annagrazia Adornetto, Maria Luisa Laganà, Andrea Satriano, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 19, pp. 10415-10415
Open Access
Pulrodemstat (CC-90011): a highly potent, selective, and reversible lysine-specific demethylase 1 (LSD1) inhibitor
Yihui Song, Bin Yu
Elsevier eBooks (2024), pp. 467-483
Closed Access
Yihui Song, Bin Yu
Elsevier eBooks (2024), pp. 467-483
Closed Access
